mlb
10-09-2005, 09:51 AM
Check out the following information from Nutra Pharma Corp. who is promoting U101 a "new" thing from Dr. Parsons in California and Stellar Pharmaceuticals.
I kind of doubt any of this is really new, but they claim they are. Is anyone using them??????????Urigen Inc. Opens IND For Phase IIb Clinical Trial With Novel Treatment For Interstitial Cystitis
VANCOUVER, British Columbia and SAN FRANCISCO, Oct. 3 /PRNewswire/ -- Urigen Inc. today announced that the United States FDA has accepted the company's investigational new drug (IND) application to initiate a Phase IIb clinical trial with its lead product, U101.
U101 is a proprietary intravesical formulation of FDA-approved components that has been demonstrated to provide near-immediate relief of symptoms associated with interstitial cystitis. The results of a successful open-label Phase IIa study were published in the Journal of Urology in February 2005 and demonstrated that administration of U101 reduced the pain and urgency associated with interstitial cystitis in patients treated with the therapy. (J. Urology 65: 45-48, 2005.)
Urigen's Phase IIb clinical trial is a prospective, randomized, double- blind, placebo-controlled Phase II study of U101 in adult subjects with chronic pelvic pain and urgency of bladder origin. The objective of the study is to evaluate the safety and efficacy of U101 in a multi-center trial.
and this....
LONDON--(BUSINESS WIRE)--May 9, 2005-- Uracyst Receives Insurance Reimbursement Approval In Germany Stellar Pharmaceuticals Inc. (OTCBB:SLXCF)(TSX VENTURE:SLX) ("Stellar") today announced that sales of Uracyst(R) have commenced in the United Kingdom through G. Pohl-Boskamp GmbH, Stellar's exclusive Pan-European licensee for this product. Stellar expects to realize sales royalties beginning this month. Uracyst is formulated to treat interstitial cystitis ("IC"), an inflammatory disease of the urinary wall whose most common symptom is the need to urgently and frequently urinate. There is no known cure for IC, nor is there a dominant treatment in the market.
(it's glousamine sulfate, I think)
I kind of doubt any of this is really new, but they claim they are. Is anyone using them??????????Urigen Inc. Opens IND For Phase IIb Clinical Trial With Novel Treatment For Interstitial Cystitis
VANCOUVER, British Columbia and SAN FRANCISCO, Oct. 3 /PRNewswire/ -- Urigen Inc. today announced that the United States FDA has accepted the company's investigational new drug (IND) application to initiate a Phase IIb clinical trial with its lead product, U101.
U101 is a proprietary intravesical formulation of FDA-approved components that has been demonstrated to provide near-immediate relief of symptoms associated with interstitial cystitis. The results of a successful open-label Phase IIa study were published in the Journal of Urology in February 2005 and demonstrated that administration of U101 reduced the pain and urgency associated with interstitial cystitis in patients treated with the therapy. (J. Urology 65: 45-48, 2005.)
Urigen's Phase IIb clinical trial is a prospective, randomized, double- blind, placebo-controlled Phase II study of U101 in adult subjects with chronic pelvic pain and urgency of bladder origin. The objective of the study is to evaluate the safety and efficacy of U101 in a multi-center trial.
and this....
LONDON--(BUSINESS WIRE)--May 9, 2005-- Uracyst Receives Insurance Reimbursement Approval In Germany Stellar Pharmaceuticals Inc. (OTCBB:SLXCF)(TSX VENTURE:SLX) ("Stellar") today announced that sales of Uracyst(R) have commenced in the United Kingdom through G. Pohl-Boskamp GmbH, Stellar's exclusive Pan-European licensee for this product. Stellar expects to realize sales royalties beginning this month. Uracyst is formulated to treat interstitial cystitis ("IC"), an inflammatory disease of the urinary wall whose most common symptom is the need to urgently and frequently urinate. There is no known cure for IC, nor is there a dominant treatment in the market.
(it's glousamine sulfate, I think)